This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JACC Specialty Journals
JACC: Advances - Lipoprotein(a): a residual cardiovascular risk factor in statin-treated stroke survivors - Insights from the SPARCL trial
Released: Sep 29, 2023
Commentary by Dr. Candice Silversides
JACC: Advances - Lipoprotein(a): a residual cardiovascular risk factor in statin-treated stroke survivors - Insights from the SPARCL trial
00:00:00
